Boston CEO
November 2-3, 2026
Mandarin Oriental Hotel, Boston
Co-hosted with leaders in the industry, join Longwood Healthcare Leaders this fall as top BioPharma executives convene for off-the-record discussions and top tier networking with BioPharma CEOs, heads of research and development, life science investors, and leading academics.
Boston CEO Co-Hosts
Boston CEO is co-hosted alongside leaders in the industry.
Bill Meury
CEO
Incyte
Company 1
Bob Langer
Koch Institute Professor, MIT
Co-Founder, Moderna
Company 1
Christoph Westphal
General Partner
Longwood Fund
Company 1
David Weinreich
Global Head, R&D
EMD Serono
Company 1
Fiona Marshall
President, Biomedical Research
Novartis
Company 1
Jane Grogan
Head, Research
Biogen
Company 2
Mathai Mammen
CEO
Parabilis
Company 2
Phil Sharp
Nobel laureate; Co-Founder, Alnylam/Biogen
Professor, MIT
Company 2
Robert Plenge
Chief Research Officer
BMS
Company 2
Featured Speakers
BioPharma CEOs
Laurent Levy
CEO
Nanobiotix
Company
Mathai Mammen
CEO
Parabilis
Company
Bill Meury
CEO
Incyte
Company
Stefan Oelrich
CEO
Bayer Pharmaceuticals
Company
Tarek Rabah
President and CEO
Otsuka North America
Company
Research & Innovation Pioneers
Susan Hockfield
President Emerita
MIT
Company
Bill Kaelin
Nobel laureate
Professor, Dana-Farber Cancer Institute
Company
Bob Langer
Koch Institute Professor, MIT
Co-Founder, Moderna
Company
Phil Sharp
Nobel laureate; Co-Founder, Alnylam/Biogen
Professor, MIT
Company
Tim Springer
Lasker; Co-Founder, Moderna/Morphic
Professor, Harvard
Company
R&D Leaders
Jane Grogan
Head, Research
Biogen
Company
Jeff Legos
Chief Oncology Officer
Pfizer
Company
Fiona Marshall
President, Biomedical Research
Novartis
Company
Robert Plenge
Chief Research Officer
BMS
Company
David Weinreich
Global Head, R&D
EMD Serono
Company
Health System & Advocacy Leaders
Julian Adams
CEO
Stand Up To Cancer
Company
Jake Auchincloss
Congressman
Massachusetts
Company
Julie Gerberding
CEO, Foundation for the NIH
former Director, CDC
Company
John O'Brien
CEO
National Pharmaceutical Council
Company
Kevin Tabb
CEO
Beth Israel Lahey Health
Company
Pharma BD & Strategy Leaders
Andrew Baum
Senior Strategic Advisor
Pfizer
Company
Matt Hefner
Global Head, BD
Kyowa Kirin
Company
Christine Roth
Head, Global Product Strategy and Commercialization
Bayer Pharmaceuticals
Company
Tolga Tanguler
CCO
Alnylam
Company
Issei Tsukamoto
SVP, Head, BD
Astellas
Company
Blue-Chip Investors
Ari Brettman
Senior Managing Director
Blackstone Life Science
Company
Jeanne Cunicelli
President
UPMC Enterprises
Company
Raymond Kelleher
Managing Director
Cormorant
Company
Cailin McGurk
Managing Director
Morgan Stanley
Company
Jason Rhodes
Partner
Atlas Venture
Company
Highlights
Boston CEO is co-hosted with leaders in the industry. See testimonials and highlights from speakers and attendees including MA Governor Maura Healey, Boston Mayor Michelle Wu, George Yancopoulos (CSO, Regeneron), Fiona Marshall (President, Biomedical Research, Novartis), Sally Kornbluth (President, MIT), Robert Plenge (Chief Research Officer, BMS), among others.
Longwood Healthcare Leaders Boston CEO 2025
Longwood Healthcare Leaders Boston CEO 2025
Longwood Healthcare Leaders Boston CEO 2024
Venue
Longwood Healthcare Leaders Boston CEO
is held at the Mandarin Oriental, Boston
2nd Floor Ballroom
776 Boylston St, Boston, MA 02199
617-535 8888
Agenda
Monday, November 2, 2026
7:00 am | Networking Breakfast
7:40 am | Biotech Market Update & Longwood Fund Introduction
Christoph Westphal, General Partner, Longwood Fund
8:00 am | Translating Science into Medicine
Laurent Levy, CEO, Nanobiotix
Michelle Longmire, CEO, Medable
Kia Motesharei, President & COO, ReAlta Life Sciences
Brendan Smith, CEO, Weaver Biosciences
Moderator: Kyle Lefkoff, General Partner, Boulder Ventures
8:30 am | Ecosystem of External Innovation
Nadim Ahmed, CEO, Cullinan Therapeutics
Jeanne Cunicelli, President, UPMC Enterprises
Scott Requadt, CEO, Prolium Bioscience
Moderator: Ferran Prat, CCO, BostonGene
9:00 am | Developing a Robust Pipeline
Giulio Draetta, Chief Strategy Officer, Orionis
Jason Luke, CMO, Strand Therapeutics
Helen Sabzevari, CEO, Precigen
Cynthia Verst, President, Design & Delivery Innovation, IQVIA
Moderator: Gilmore O’Neill, CEO, Editas Medicine
9:30 am | Fireside Chat
Phil Sharp, Nobel laureate; Co-Founder, Alnylam/Biogen; Professor, MIT
Tim Springer, Lasker; Co-Founder, Moderna/Morphic; Professor, Harvard
Moderator: Christoph Westphal, Founder/CEO/Lead Investor, Alnylam
9:50 am | Networking Break
10:15 am | R&D Collaboration
Alexandria Cogdill, Head, Strategic Initiatives, Global BD, Daiichi Sankyo
Julie Gerberding, CEO, Foundation for the NIH; former Director, CDC
Benjamin Moutier, SVP, Infectious Disease, AstraZeneca
Shinji Okitsu, Head, Research Strategic Collaborations & Partnerships, Sanofi
Stef van Grieken, CEO, Cradle
Moderator: Brad Margus, Chair, Cerevance; Chair, A-T Children’s Project
10:50 am | Delivering the Next Generation of Diagnostics
Julian Adams, CEO, Stand Up To Cancer
Vera Grossmann, Interim CEO, Foundation Medicine
Bharat Tewarie, CEO, Helio Genomics
Jeffrey Venstrom, CMO, ClearNote Health
Roman Yelensky, VP, Clinical Applications, 10x Genomics
Moderator: Rehan Verjee, CEO, Precede Bio
11:25 am | Competing in a New Global Playing Field
Judy Chou, CEO, AltruBio
Ruxandra Draghia-Akli, Chair, Scientific Advisory Board, INTREPID Alliance
Kenneth Moch, CEO, Regerna Therapeutics
Ming Wang, CEO, Phanes Therapeutics
Moderator: Raj Prasad, CFO, Crispr Therapeutics
11:55 am | Biomedical Superintelligence & the Future of R&D
Venky Soundararajan, CEO, nference
12:15 pm | Networking Luncheon
1:00 pm | Fireside Chat
Bob Langer, Koch Institute Professor, MIT; Co-Founder, Moderna
Bill Kaelin, Nobel laureate; Professor, Dana-Farber Cancer Institute
Moderator: Christoph Westphal, Founder/CEO/Lead Investor, Alnylam
1:20 pm | Leveraging an Effective Board
Tim Noyes, CEO, Newleos
Rob Perez, Chair, Life Science Cares
Mike Rosenblatt, Senior Advisor, Flagship Pioneering; former CMO, Merck
Rogerio Vivaldi, Chair, Vesper Biotechnologies
Moderator: Bill Heiden, Chair, Macrogenics
1:50 pm | Biopharma Pipeline Sourcing
Bruno Gomes, Global Head, Oncology Research & Early Development, Roche
Erin Kimbrel, Head, Cell & Gene Therapy Research, Astellas
Francisco Leon, CEO, Tolerance Bio
Oliver Vince, COO, Basecamp Research
Moderator: Sekhar Naik, CEO, MResult
2:20 pm | Driving Productivity in R&D
Manuel Aivado, CEO, Stelexis
Rachel Humphrey, CEO, Normunity
Samir Khleif, CEO, Georgiamune
Sarah Sheikh, Head, Global Development & SVP, Neuroscience, Takeda
Moderator: Yiannis Kiachopoulos, CEO, Causaly
2:50 pm | Networking Break
3:10 pm | Bolstering the Regulatory Strategy
Andrew Baum, Senior Strategic Advisor, Pfizer
Fawzi Benzaghou, former Global Head, Oncology, Ipsen
Adora Ndu, Chief Regulatory Affairs Officer, BridgeBio
Tolga Tanguler, CCO, Alnylam
Moderator: Chandra Ramanathan, EVP, Commercialization & Strategy, BRC Therapeutics
3:40 pm | Capital Formation and Strategic Partnerships
Reza Afkhami, CBO, Kamau Therapeutics
Jeff Aronin, CEO, Paragon Biosciences
John Butler, CEO, Akebia Therapeutics
Sean McCarthy, CEO, CytomX
Moderator: Tim Ehrlich, Partner, Gunderson Dettmer
4:10 pm | Expanding upon the Potential of Scientific Innovation
Sharon Benzeno, CCO, Adaptive Biotechnologies
Eran Harary, CMO, Remepy
Craig Martin, CEO, Orphan Therapeutics Accelerator
Tommy Sowers, Vice Chancellor, Innovation, Entrepreneurship & Economic Development, UNC Chapel Hill
Brent Vaughan, CEO, Eratos Therapeutics
Moderator: Skip Virgin, Head, AI Enabled Cures Frontiers, Gates Foundation
4:45 pm | Investor Outlook
Peter Bisgaard, Managing Director, Pivotal Life Sciences
Rakhshita Dhar, Head, Healthcare Investments, Leaps by Bayer
Raymond Kelleher, Managing Director, Cormorant
Moderator: Vikas Goyal, Partner, Longwood Fund
Tuesday, November 3, 2026
7:00 am | Networking Breakfast
7:40 am | Biotech Market Update & Longwood Fund Introduction
Vikas Goyal, Partner, Longwood Fund
8:00 am | Building Global BioPharmas
Matt Klein, CEO, PTC Therapeutics
Pedro Lichtinger, CEO, Starton Therapeutics
Smita Pillai, SVP, Head, Innovation Center, Regeneron
David Roblin, CEO, Relation
Moderator: Richard Paulson, CEO, Karyopharm
8:30 am | Drug Approvals: Insights, Outlook, and Commitment to Patients
Annette Bakker, CEO, Children's Tumor Foundation
Jean-Frédéric Paulsen, CEO, Ferring Pharmaceuticals
Raviv Pryluk, CEO, PhaseV
Christine Roth, Head, Global Product Strategy and Commercialization, Bayer Pharmaceuticals
Moderator: Tamar Thompson, Head, Global Patient Experience, Alexion
9:00 am | Crossroads of Science and Policy: Sustaining the Engine of Innovation
Jake Auchincloss, Congressman, Massachusetts
Susan Hockfield, President Emerita, MIT
Tarek Rabah, President & CEO, Otsuka North America
Kevin Tabb, CEO, Beth Israel Lahey Health
Moderator: John O’Brien, CEO, National Pharmaceutical Council
9:30 am | Fireside Chat
Jane Grogan, Head, Research, Biogen
Jeff Legos, Chief Oncology Officer, Pfizer
Robert Plenge, Chief Research Officer, BMS
9:55 am | Networking Break
10:20 am | Prioritizing the Pipeline
Christina Coughlin, CEO, Avacta Therapeutics
Marion Dorsch, CSO, Atavistik Bio
Andrew Hirsch, CEO, C4 Therapeutics
Richard Wilson, SVP, Primary Focus Lead, Genetic Regulation, Astellas
Moderator: Dipal Doshi, CEO, Entrada
10:50 am | Advancing Late-Stage Assets
Stewart Campbell, CEO, Novita Pharmaceuticals
Abe Ceesay, CEO, Rapport Therapeutics
Anna Kazanchyan, CEO, Saghmos Therapeutics
Neil Warma, CEO, ProMIS Neurosciences
Moderator: Robert Stanislaro, Senior Managing Director, FTI Consulting
11:20 am | Managing the Runway
Chris Loose, CEO, Progentos
Joanna Stanicka, CEO, Axonis
Joe Stauffer, CMO, PVP Labs
Leslie Williams, CEO, DaCapo Brainscience
Moderator: Rick Lundberg, CEO, Eikonizo
11:50 am | CEO Chat: What it takes to Build a Great Company
Mathai Mammen, CEO, Parabilis
Bill Meury, CEO, Incyte
Moderator: Seema Kumar, CEO, Cure.
12:15 pm | Networking Luncheon
1:15 pm | Targeted Licensing & Acquisitions
Matt Hefner, Global Head, BD, Kyowa Kirin
Jeff Landau, CEO, Stipple Bio
Karen Reeves, SVP, Investments & Head Clinical Strategy
Rick Russell, CEO, Tract Bio
Moderator: Zhen Su, CEO, Marengo Therapeutics
1:45 pm | Accelerating Drug Discovery
Aris Baras, SVP, Head, Regeneron Genetics Center
Jacob Hooker, CEO, Sensorium Therapeutics
Szabi Nagy, CEO, Turbine
Phil Vickers, CEO, Solu Therapeutics
Moderator: Kara Carter, CEO, Viraccio Therapeutics
2:15 pm | Developing High-Performing Teams
Laura Benjamin, CEO, Myris Therapeutics
Nenad Grmusa, CEO, DEM BioPharma
Wyatt McDonnell, CEO, Infinimmune
Quin Wills, CEO, Ochre Bio
Lilly Wollman, CEO, Synteny
Moderator: Isaac Klein, President, Dewpoint Therapeutics
2:50 pm | Networking Break
3:15 pm | Positioning for Commercial Success
Nathan Hubbard, CEO, Flatiron Health
Kabir Nath, CEO, COMPASS Pathways
Karin Shanahan, EVP, Chief Supply Chain & Operations Officer, BMS
Dennis Velasquez, CCO, Biorce
Moderator: Vikram Karnani, CEO, Collegium Pharmaceutical
3:45 pm | Fireside Chat
Fiona Marshall, President, Biomedical Research, Novartis
David Weinreich, Global Head, R&D, EMD Serono
Moderator: Sekhar Naik, CEO, MResult
4:05 pm | The Evolving Deal-Making Landscape
Al Beardsley, CEO, Cirius Therapeutics
Hannah England, Partner, Ropes & Gray
Murray McCutcheon, SVP, Partnering, AbCellera
Issei Tsukamoto, SVP, Head, BD, Astellas
Moderator: Philippe Lopes-Fernandes, CBO, Ipsen
4:35 pm | Evaluating Investment Risk
Ari Brettman, Senior Managing Director, Blackstone Life Science
Cailin McGurk, Managing Director, Morgan Stanley
Pini Orbach, Managing Partner & Head, Pharma, Arkin Capital
Jason Rhodes, Partner, Atlas Venture
Moderator: Aleks Radovic-Moreno, Partner, Longwood Fund
5:00 pm | Cocktail Reception
Speaking Faculty
Julian Adams
CEO
Stand Up To Cancer
Company
Jake Auchincloss
Congressman
Massachusetts
Company
Laura Benjamin
CEO
Myris Therapeutics
Company
John Butler
CEO
Akebia Therapeutics
Company
Alexandria Cogdill
Head, Strategic Initiatives, Global BD
Daiichi Sankyo
Company
Dipal Doshi
CEO
Entrada
Company
Julie Gerberding
CEO, Foundation for the NIH
former Director, CDC
Company
Jane Grogan
Head, Research
Biogen
Company
Bill Heiden
Chair
MacroGenics
Company
Rachel Humphrey
CEO
Normunity
Company
Samir Khleif
CEO
Georgiamune
Company
Anne Klibanski
CEO
Mass General Brigham
Company
Jeff Legos
Chief Oncology Officer
Pfizer
Company
Chris Loose
CEO
Progentos
Company
Brad Margus
Chair, Cerevance
Chair, A-T Children's Project
Company
Wyatt McDonnell
CEO
Infinimmune
Company
Benjamin Moutier
SVP, Infectious Disease
AstraZeneca
Company
Tim Noyes
CEO
Newleos
Company
Jean-Frédéric Paulsen
CEO
Ferring Pharmaceuticals
Company
Raj Prasad
CFO
CRISPR Therapeutics
Company
Chandra Ramanathan
EVP, Commercialization & Strategy
BRC Therapeutics
Company
Mike Rosenblatt
Senior Advisor, Flagship Pioneering
former CMO, Merck
Company
Phil Sharp
Nobel laureate; Co-Founder, Alnylam/Biogen
Professor, MIT
Company
Tim Springer
Lasker; Co-Founder, Moderna/Morphic
Professor, Harvard
Company
Kevin Tabb
CEO
Beth Israel Lahey Health
Company
Brent Vaughan
CEO
Eratos Therapeutics
Company
Phil Vickers
CEO
Solu Therapeutics
Company
Neil Warma
CEO
ProMIS Neurosciences
Company
Richard Wilson
SVP, Primary Focus Lead, Genetic Regulation
Astellas
Company
Reza Afkhami
CBO
Kamau Therapeutics
Company
Annette Bakker
CEO
Children's Tumor Foundation
Company
Fawzi Benzaghou
former Global Head, Oncology, Ipsen
CMO, Parabilis
Company
Stewart Campbell
CEO
Novita Pharmaceuticals
Company
Christina Coughlin
CEO
Avacta Therapeutics
Company
Giulio Draetta
Chief Strategy Officer
Orionis
Company
Bruno Gomes
Global Head, Oncology Research & Early Development
Roche
Company
Vera Grossmann
Interim CEO
Foundation Medicine
Company
Andrew Hirsch
CEO
C4 Therapeutics
Company
Bill Kaelin
Nobel laureate
Professor, Dana-Farber Cancer Institute
Company
Yiannis Kiachopoulos
CEO
Causaly
Company
Seema Kumar
CEO
Cure.
Company
Francisco Leon
CEO
Tolerance Bio
Company
Philippe Lopes-Fernandes
CBO
Ipsen
Company
Fiona Marshall
President, Biomedical Research
Novartis
Company
Cailin McGurk
Managing Director
Morgan Stanley
Company
Szabi Nagy
CEO
Turbine
Company
John O'Brien
CEO
National Pharmaceutical Council
Company
Richard Paulson
CEO
Karyopharm
Company
Ferran Prat
CCO
BostonGene
Company
Karen Reeves
SVP, Investments & Head, Clinical Strategy
Ligand
Company
Christine Roth
Head, Global Product Strategy and Commercialization
Bayer Pharmaceuticals
Company
Sarah Sheikh
Head, Global Development & SVP, Neuroscience
Takeda
Company
Joanna Stanicka
CEO
Axonis
Company
Tolga Tanguler
CCO
Alnylam
Company
Dennis Velasquez
CCO
Biorce
Company
Oliver Vince
COO
Basecamp Research
Company
David Weinreich
Global Head, R&D
EMD Serono
Company
Lilly Wollman
CEO
Synteny
Company
Nadim Ahmed
CEO
Cullinan Therapeutics
Company
Aris Baras
SVP, Head
Regeneron Genetics Center
Company
Sharon Benzeno
CCO
Adaptive Biotechnologies
Company
Kara Carter
CEO
Viraccio Therapeutics
Company
Jeanne Cunicelli
President
UPMC Enterprises
Company
Ruxandra Draghia-Akli
Chair, Scientific Advisory Board
INTREPID Alliance
Company
Vikas Goyal
Partner
Longwood Fund
Company
Eran Harary
CMO
Remepy
Company
Susan Hockfield
President Emerita
MIT
Company
Vikram Karnani
CEO
Collegium Pharmaceutical
Company
Erin Kimbrel
Head, Cell & Gene Therapy Research
Astellas
Company
Jeff Landau
CEO
Stipple Bio
Company
Laurent Levy
CEO
Nanobiotix
Company
Jason Luke
CMO
Strand Therapeutics
Company
Craig Martin
CEO
Orphan Therapeutics Accelerator
Company
Bill Meury
CEO
Incyte
Company
Sekhar Naik
CEO
MResult
Company
Shinji Okitsu
Head, Research Strategic Collaborations & Partnerships
Sanofi
Company
Rob Perez
Chair
Life Science Cares
Company
Raviv Pryluk
CEO
PhaseV
Company
Scott Requadt
CEO
Prolium Bioscience
Company
Rick Russell
CEO
Tract Bio
Company
Brendan Smith
CEO
Weaver Biosciences
Company
Robert Stanislaro
Senior Managing Director
FTI Consulting
Company
Bharat Tewarie
CEO
Helio Genomics
Company
Jeffrey Venstrom
CMO
ClearNote Health
Company
Skip Virgin
Head, AI Enabled Cures Frontiers
Gates Foundation
Company
Christoph Westphal
General Partner
Longwood Fund
Company
Roman Yelensky
VP, Clinical Applications
10x Genomics
Company
Manuel Aivado
CEO
Stelexis
Company
Andrew Baum
Senior Strategic Advisor
Pfizer
Company
Peter Bisgaard
Managing Director
Pivotal Life Sciences
Company
Abe Ceesay
CEO
Rapport Therapeutics
Company
Rakhshita Dhar
Head, Healthcare Investments
Leaps by Bayer
Company
Tim Ehrlich
Partner
Gunderson Dettmer
Company
Stef van Grieken
CEO
Cradle
Company
Maura Healey
Governor
Commonwealth of Massachusetts
Company
Jacob Hooker
CEO
Sensorium Therapeutics
Company
Anna Kazanchyan
CEO
Saghmos Therapeutics
Company
Isaac Klein
President
Dewpoint Therapeutics
Company
Bob Langer
Koch Institute Professor, MIT
Co-Founder, Moderna
Company
Pedro Lichtinger
CEO
Starton Therapeutics
Company
Rick Lundberg
CEO
Eikonizo
Company
Sean McCarthy
CEO
CytomX
Company
Kenneth Moch
CEO
Regerna Therapeutics
Company
Kabir Nath
CEO
COMPASS Pathways
Company
Gilmore O'Neill
CEO
Editas Medicine
Company
Smita Pillai
SVP, Head, Innovation Center
Regeneron
Company
Tarek Rabah
President and CEO
Otsuka North America
Company
Jason Rhodes
Partner
Atlas Venture
Company
Helen Sabzevari
CEO
Precigen
Company
Venky Soundararajan
CEO
nference
Company
Joe Stauffer
CMO
PVP Labs
Company
Tamar Thompson
Head, Global Patient Experience
Alexion
Company
Rehan Verjee
CEO
Precede Bio
Company
Rogerio Vivaldi
Chair
Vesper Biotechnologies
Company
Leslie Williams
CEO
DaCapo Brainscience
Company
Jeff Aronin
CEO
Paragon Biosciences
Company
Al Beardsley
CEO
Cirius Therapeutics
Company
Ari Brettman
Senior Managing Director
Blackstone Life Science
Company
Judy Chou
CEO
AltruBio
Company
Marion Dorsch
CSO
Atavistik Bio
Company
Hannah England
Partner
Ropes & Gray
Company
Nenad Grmusa
CEO
DEM BioPharma
Company
Matt Hefner
Global Head, BD
Kyowa Kirin
Company
Nathan Hubbard
CEO
Flatiron Health
Company
Raymond Kelleher
Managing Director
Cormorant
Company
Matt Klein
CEO
PTC Therapeutics
Company
Kyle Lefkoff
General Partner
Boulder Ventures
Company
Michelle Longmire
CEO
Medable
Company
Mathai Mammen
CEO
Parabilis
Company
Murray McCutcheon
SVP, Partnering
AbCellera
Company
Adora Ndu
Chief Regulatory Affairs Officer
BridgeBio
Company
Pini Orbach
Managing Partner & Head, Pharma
Arkin Capital
Company
Robert Plenge
Chief Research Officer
BMS
Company
Aleks Radovic-Moreno
Partner
Longwood Fund
Company
David Roblin
CEO
Relation
Company
Karin Shanahan
EVP, Chief Supply Chain & Operations Officer
BMS
Company
Tommy Sowers
Vice Chancellor, Innovation, Entrepreneurship & Economic Development
UNC Chapel Hill
Company
Zhen Su
CEO
Marengo Therapeutics
Company
Issei Tsukamoto
SVP, Head, BD
Astellas
Company
Cynthia Verst
President, Design & Delivery Innovation
IQVIA
Company
Ming Wang
CEO
Phanes Therapeutics
Company
Quin Wills
CEO
Ochre Bio
Company
